BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19926735)

  • 1. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection.
    Goletti D; Butera O; Vanini V; Lauria FN; Lange C; Franken KL; Angeletti C; Ottenhoff TH; Girardi E
    Eur Respir J; 2010 Jul; 36(1):135-42. PubMed ID: 19926735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.
    Chiacchio T; Petruccioli E; Vanini V; Butera O; Cuzzi G; Petrone L; Matteucci G; Lauria FN; Franken KL; Girardi E; Ottenhoff TH; Goletti D
    PLoS One; 2011; 6(11):e27539. PubMed ID: 22102905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Hit
    Adankwah E; Lundtoft C; Güler A; Franken KLMC; Ottenhoff THM; Mayatepek E; Owusu-Dabo E; Phillips RO; Nausch N; Jacobsen M
    Front Immunol; 2019; 10():1518. PubMed ID: 31333654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection.
    Amiano NO; Morelli MP; Pellegrini JM; Tateosian NL; Rolandelli A; Seery V; Castello FA; Gallego C; Armitano R; Stupka J; Erschen MA; Ciallella LM; de Casado GC; Cusmano L; Palmero DJ; Iovanna JL; García VE
    Sci Rep; 2020 May; 10(1):7472. PubMed ID: 32366931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.
    Peña D; Rovetta AI; Hernández Del Pino RE; Amiano NO; Pasquinelli V; Pellegrini JM; Tateosian NL; Rolandelli A; Gutierrez M; Musella RM; Palmero DJ; Gherardi MM; Iovanna J; Chuluyan HE; García VE
    EBioMedicine; 2015 Aug; 2(8):884-90. PubMed ID: 26425695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.
    Leyten EM; Lin MY; Franken KL; Friggen AH; Prins C; van Meijgaarden KE; Voskuil MI; Weldingh K; Andersen P; Schoolnik GK; Arend SM; Ottenhoff TH; Klein MR
    Microbes Infect; 2006 Jul; 8(8):2052-60. PubMed ID: 16931093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan.
    Hozumi H; Tsujimura K; Yamamura Y; Seto S; Uchijima M; Nagata T; Miwa S; Hayakawa H; Fujisawa T; Hashimoto D; Inui N; Suda T; Chida K; Koide Y
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):818-24. PubMed ID: 23676169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts.
    Pandey K; Singh S; Bhatt P; Medha ; Sharma M; Chaudhry A; Sharma S
    Microb Pathog; 2019 Jan; 126():399-406. PubMed ID: 30476579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of
    Kimuda SG; Nalwoga A; Levin J; Franken KL; Ottenhoff TH; Elliott AM; Cose S; Andia-Biraro I
    J Immunol Res; 2017; 2017():1593143. PubMed ID: 28255560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia.
    Riaño F; Arroyo L; París S; Rojas M; Friggen AH; van Meijgaarden KE; Franken KL; Ottenhoff TH; García LF; Barrera LF
    Tuberculosis (Edinb); 2012 Mar; 92(2):148-59. PubMed ID: 22226907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.